EU-Project NAMDIATREAM with partner Jean-Pierre Wolf
Through FutureFlash! Best Project competition, EuroNanoForum 2015 has identified and selected 10 very best of all the over 1 000 projects launched under the EU Funding Instruments in the field of nanotechnologies and advanced materials.
NAMDIATREAM, terminated in June 2014, has successfully developed innovative diagnostic devices for the early diagnosis of 3 common cancer types (lung, breast and prostate) representing more than 4,5 million worldwide cancer cases in the year 2012. NAMDIATREAM technology is based on cutting edge nanotechnology-based tools for multi-modal detection of biomarkers, permitting identification of cells indicative of early disease onset in a high-specificity and throughput format in clinical, laboratory and point-of-care devices.
NAMDIATREAM, terminated in June 2014, has successfully developed innovative diagnostic devices for the early diagnosis of 3 common cancer types (lung, breast and prostate) representing more than 4,5 million worldwide cancer cases in the year 2012. NAMDIATREAM technology is based on cutting edge nanotechnology-based tools for multi-modal detection of biomarkers, permitting identification of cells indicative of early disease onset in a high-specificity and throughput format in clinical, laboratory and point-of-care devices.